Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 45 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Be in good general health
Be able to participate for 4-15 months
Pregnant or planning pregnancy
History of malaria or exposure to malaria in past 12 months
Received an investigational malaria vaccine
Past history of allergic reaction to previous immunization
Positive blood tests for HIV and specific types of hepatitis